The cluster is dominated by a single large sale from the EVP of North America that is mechanically linked to option exercises — a classic cashless exercise pattern that does not convey negative information. The total dollar value is trivial relative to the $8.0B market cap (0.12%). Per academic literature, cluster sales are not predictive of negative returns, and the strong Q2 beat and raised pipeline outlook provide a positive fundamental backdrop. No bearish read-through is warranted.
Price Chart
Executive Summary
Three Rhythm Pharmaceuticals executives sold a total of $9.77M in open-market stock within a week of the company's strong Q2 2026 earnings beat. The sales are concentrated in the EVP of North America (Jennifer Kayden Lee, $8.9M) and follow a period of significant stock appreciation, suggesting profit-taking and option exercise monetization rather than a bearish signal on fundamentals.
Key Financial Metrics
Key Facts
- Three insiders sold a total of $9.77M in open-market stock from Aug 12-13, 2026.
- EVP Jennifer Kayden Lee accounted for $8.9M of the total, selling 75,834 shares at ~$117.38.
- All sales occurred 8-9 days after the company reported a Q2 2026 revenue beat ($71.3M vs $67.7M consensus) and a 12% EPS beat.
- The $9.77M in sales represents approximately 0.12% of RYTM's $8.0B market cap.
- Lee's sales were accompanied by the exercise of 56,601 stock options at $0-$24.29 strike prices, indicating a cashless exercise-and-sell pattern.
- CTO Joseph Shulman and CSO Alastair Garfield also sold shares totaling $608K and $913K respectively.
Financial Impact
$9.77M in insider sales, or 0.12% of market cap
Risk Factors
- Insider selling could accelerate if the stock continues to appreciate, creating overhead supply.
- The concentration of sales in the North America commercial head may signal a personal liquidity event rather than a company-specific concern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-RYTM-1787004110005 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 17d ago | 144 | $96.77 $99.27 | ▼ −2.58% | ▼ −0.47% | $93.68 (+3.19%) |
Aug 17, 2026 6w ago | Insider Cluster | $115.25 $113.35 | ▲ +1.65% | ▲ +1.45% | $93.68 (+18.72%) |
Aug 17, 2026 6w ago | Insider Cluster | $115.25 $113.35 | ▼ −1.65% | ▼ −1.45% | $93.68 (−18.72%) |
Aug 4, 2026 8w ago | 8-K | $105.78 $112.85 | ▲ +6.68% | ▲ +6.78% | $93.68 (−11.44%) |
Aug 4, 2026 8w ago | Press Release | $105.78 $112.85 | ▲ +6.68% | ▲ +6.78% | $93.68 (−11.44%) |
Jul 8, 2026 12w ago | Press Release | $115.48 $106.09 | ▼ −8.13% | ▼ −8.00% | $93.68 (−18.88%) |
Jun 22, 2026 14w ago | 144 | $106.19 $110.04 | ▲ +3.63% | ▲ +2.61% | $93.68 (−11.78%) |
Jun 15, 2026 15w ago | 8-K | $89.72 $106.19 | ▲ +18.36% | ▲ +20.59% | $93.68 (+4.41%) |
Jun 15, 2026 15w ago | Press Release | $89.72 $106.19 | ▲ +18.36% | ▲ +20.59% | $93.68 (+4.41%) |
Jun 13, 2026 15w ago | Press Release | $89.70 $101.39 | ▲ +13.03% | ▲ +14.42% | $93.68 (+4.44%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access